does glp 1 cause heavy periods GLP-1 Receptor Agonists, Fertility Restoration, and Reproductive Safety in Women of Reproductive Age: A Narrative Review GLP-1 in Endometriosis: What We

Lack of Human Studies Most research has been conducted in animal models

Arnal E, Miranda M, Almansa I, et al

WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk

ParohanMDjalaliMSarrafPYaghoubiSSerajAForoushaniARet al

Quercetin's ability to scavenge free radicals and inhibit lipid peroxidation is well documented (Boots et al

Data were processed using Profinder 10.0 software